This consequently causes increased mRNA translation and promotes tumorigenic phenotypes of GBM, including stemness, cell growth, resistance to temozolomide, and migration in vitro and in vivo, suggesting that NSUN5 can be a potential therapeutic target to treat GBM. Here, NSUN5 is linked to glioblastoma.